Clinical Evidence 

CHAMPION and CardioMEMS clinical studies have shown that PAP-guided HF management reduces hospital length of stay by 42% (1.6 days) and 30-day readmissions by 58% compared to the standard of care.   (Ref. 1,2,4)

References

1. Abraham WT et al. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomized control study (CHAMPION Trial). Lancet. 2011 Feb 19;377(9766):658-66
2. Adamson PB et al. Pulmonary Artery Pressure–Guided Heart Failure Management Reduces 30-Day Readmissions. Circ Heart Fail. 2016;9:e002600.  
3. CHAMPION Clinical Trial, ClinicalTrials.gov number NCT00531661
4. Abraham, WT et al. Pulmonary artery pressure management in heart failure patients - significantly reduces heart failure hospitalizations and mortality. vol. 65 no. 10, ACC 2015